Skip to content

Sleep Intervention to Improve Glycemic Control in Women With Gestational Diabetes

Sleep Intervention to Improve Glycemic Control in Women With Gestational Diabetes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03266133
Enrollment
74
Registered
2017-08-29
Start date
2017-11-27
Completion date
2019-06-30
Last updated
2019-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational Diabetes Mellitus in Pregnancy

Keywords

Gestational Diabetes Mellitus, Sleep education

Brief summary

This is a pilot randomized controlled trial involving a sleep education intervention in women with gestational diabetes to study whether sleep education during pregnancy leads to improvement in glycemic control in women with gestational diabetes and improvement in sleep duration.

Detailed description

Patients will be identified from the Maternal-Fetal Medicine office and the Perinatal Assessment Clinic at Magee-Womens Hospital, University of Pittsburgh Medical Center. Patients with gestational diabetes will be recruited following general education regarding gestational diabetes in pregnancy which is universally done for all patients at the time of their diagnosis of gestational diabetes. Eligible subjects will be randomized to two groups (usual care vs. sleep education program).

Interventions

BEHAVIORALSleep Education for Pregnancy

Sleep education specific to pregnancy

Sponsors

University of Pittsburgh
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

1. Pregnant female 2. Ages 18-50 3. Gestational age between 16 0/7 weeks and 31 6/7 weeks 4. New diagnosis of GDM, not on treatment (i.e., insulin, glyburide, or metformin) at the time of enrollment

Exclusion criteria

1. Children less than 18 years of age 2. Non-English speaking 3. Multiple gestations (twins, triplets, etc)

Design outcomes

Primary

MeasureTime frameDescription
Glycemic control3-6 months during pregnancyProportion of participants achieving glycemic control at study end. Glycemic control defined as greater than 75% of weeks with average fasting blood glucose \< 95 mg/dL and 1-hr postprandial blood glucose \<140 mg/dL.
Self-reported sleep duration3-6 months during pregnancyProportion of patients who report sleeping between 7-9 hours per night

Secondary

MeasureTime frameDescription
Gestational age at deliveryTime of delivery
Neonatal birth weightTime of delivery
Average fasting glucose values3-6 months during pregnancy
Route of deliveryTime of deliveryMedical records will be reviewed to determine if the patient had a vaginal delivery or cesarean delivery.
PreeclampsiaTime of deliveryMedical records will be reviewed to determine whether a patient had a diagnosis of preeclampsia prior to delivery.
Indication for deliveryTime of deliveryMedical records will be used to determine whether a patient when into spontaneous labor, had an induction or labor or a recommended delivery by cesarean section. If the patient had an induction or labor or a recommended cesarean delivery, the indication for this recommendation will be recorded.
Average postprandial glucose values3-6 months during pregnancy

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026